Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stem cell
Pharma
NICE says no dice to Orchard's pricey therapy for rare disease
Orchard Therapeutics' gene therapy for rare and fatal MLD has been approved by the EU. But NICE has rejected it because of its high price tag.
Kevin Dunleavy
Jul 9, 2021 10:43am
Apceth Biopharma gets contract to manufacture Zynteglo
Jun 4, 2019 9:24am
Merck antiviral drug Prevymis wins NICE over
May 30, 2019 12:06pm
Korean biotechs snatch U.S. stem cell manufacturing facility
Feb 13, 2019 12:00pm
Biotech tied to GSK to build cell production facility in U.S.
Oct 8, 2018 11:27am
Novo picks up stem cell production plant from Asterias
Oct 1, 2018 12:06pm
